Theravance Biopharma saw the highest growth of 49% in patent filings in January and 249% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 49% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of Theravance Biopharma‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Theravance Biopharma has been focused on protecting inventions in United States(US) with five publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 30% grants. The United States(US), European Patent Office(EPO), Israel(IL), and Canada(CA) patent Office are among the top ten patent offices where Theravance Biopharma is filings its patents. Among the top granted patent authorities, Theravance Biopharma has 30% of its grants in United States(US), 20% in Israel(IL) and 10% in European Patent Office(EPO).

Bayer and F. Hoffmann-La Roche could be the strongest competitors for Theravance Biopharma

Patents related to rare diseases and Covid-19 lead Theravance Biopharma's portfolio

Theravance Biopharma has the highest number of patents in rare diseases followed by, Covid-19. For rare diseases, nearly 67% of patents were filed and 100% of patents were granted in Q1 2024.

Chronic obstructive pulmonary disease (copd) related patents lead Theravance Biopharma portfolio followed by asthma, and acute lung injury

Theravance Biopharma has highest number of patents in chronic obstructive pulmonary disease (copd) followed by asthma, acute lung injury, sarcoidosis, and lung transplant rejection. For chronic obstructive pulmonary disease (copd), nearly 4% of patents were filed and 4% of patents were granted in Q1 2024.

For comprehensive analysis of Theravance Biopharma's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.